Epoch Times
By Zachary Stieber
January 12, 2022 Updated: January 12, 2022
Food and Drug Administration officials on Tuesday added a bleeding risk to fact sheets for Johnson & Johnson’s COVID-19 vaccine.
Healthcare providers administering the vaccine and recipients and caregivers are now being told that there’s a safety signal for immune thrombocytopenia, a disorder stemming from low platelet levels that can cause excessive bleeding.